Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor

FASEB Journal

Volumn 25, Issue 4, 2011, Pages 1188-1197

  Liu, Xin ^a   Zhao, Dezheng ^a,b   James, Lauralee ^a,b   Li, Jian ^a   Zeng, Huiyan ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

DSCR1; TEF3; VEGF

Indexed keywords

F ACTIN; MATRIGEL; TRANSCRIPTION ENHANCER FACTOR 3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ACTINS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DNA-BINDING PROTEINS; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; MICE; MUSCLE PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR LOCALIZATION SIGNALS; PROTEOGLYCANS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 79954569852     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-167619     Document Type: Article

References (19)

1. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31
2. Folkman, J., and D'Amore, P. A. (1996) Blood vessel formation: what is its molecular basis? Cell 87, 1153-1155 (Pubitemid 27010098)
3. Folkman, J. (1997) Angiogenesis and angiogenesis inhibition: an overview. EXS 79, 1-8
4. Qin, L., Zhao, D., Liu, X., Nagy, J. A., Hoang, M. V., Brown, L. F., Dvorak, H. F., and Zeng, H. (2006) Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway. Mol. Cancer Res. 4, 811-820 (Pubitemid 44877011)
5. Liu, X., Zhao, D., Qin, L., Li, J., and Zeng, H. (2008) Transcription enhancer factor 3 (TEF3) mediates the expression of down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells. J. Biol. Chem. 283, 34159-34167
6. Ryeom, S., Baek, K. H., Rioth, M. J., Lynch, R. C., Zaslavsky, A., Birsner, A., Yoon, S. S., and McKeon, F. (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell 13, 420-431 (Pubitemid 351609439)
7. Farrance, I. K., and Ordahl, C. P. (1996) The role of transcription enhancer factor-1 (TEF-1) related proteins in the formation of M-CAT binding complexes in muscle and non-muscle tissues. J. Biol. Chem. 271, 8266-8274 (Pubitemid 26108659)
8. Yockey, C. E., Smith, G., Izumo, S., and Shimizu, N. (1996) cDNA cloning and characterization of murine transcriptional enhancer factor-1-related protein 1, a transcription factor that binds to the M-CAT motif. J. Biol. Chem. 271, 3727-3736 (Pubitemid 26065692)
9. Stewart, A. F., Richard, C. W., 3rd, Suzow, J., Stephan, D., Weremowicz, S., Morton, C. C., and Adra, C. N. (1996) Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multigene family. Genomics 37, 68-76 (Pubitemid 26341836)
10. Stewart, A. F., Suzow, J., Kubota, T., Ueyama, T., and Chen, H. H. (1998) Transcription factor RTEF-1 mediates alpha1-adrenergic reactivation of the fetal gene program in cardiac myocytes. Circ. Res. 83, 43-49 (Pubitemid 28322098)
11. Chen, H. H., Baty, C. J., Maeda, T., Brooks, S., Baker, L. C., Ueyama, T., Gursoy, E., Saba, S., Salama, G., London, B., and Stewart, A. F. (2004) Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation. Circulation 110, 2980-2987 (Pubitemid 39491987)
12. Yagi, R., Kohn, M. J., Karavanova, I., Kaneko, K. J., Vullhorst, D., DePamphilis, M. L., and Buonanno, A. (2007) Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development 134, 3827-3836 (Pubitemid 350187342)
13. Shie, J. L., Wu, G., Wu, J., Liu, F. F., Laham, R. J., Oettgen, P., and Li, J. (2004) RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J. Biol. Chem. 279, 25010-25016 (Pubitemid 38756749)
14. Hayashi, K., Ohkura, N., Miki, K., Osada, S., and Tomino, Y. (1996) Early induction of the NGFI-B/Nur77 family genes in nephritis induced by anti-glomerular basement membrane antibody. Mol. Cell. Endocrinol. 123, 205-209 (Pubitemid 26402149)
15. Hoang, M. V., Whelan, M. C., and Senger, D. R. (2004) Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 101, 1874-1879 (Pubitemid 38228984)
16. Zeng, H., Dvorak, H. F., and Mukhopadhyay, D. (2001) Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J. Biol. Chem. 1276, 26969-26979
17. Zeng, H., Qin, L., Zhao, D., Tan, X., Manseau, E. J., Van Hoang, M., Senger, D. R., Brown, L. F., Nagy, J. A., and Dvorak, H. F. (2006) Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J. Exp. Med. 203, 719-729
18. Nagy, J., Feng, D., Vasile, E., Wong, W., Shih, S. C., Dvorak, A., and Dvorak., H. (2006) Permeability properties of tumor surrogate blood vessels induced by VEGF-A. Lab. Invest. 86, 767-780 (Pubitemid 44100476)
19. Pettersson, A., Nagy, J. A., Brown, L. F., Sundberg, C., Morgan, E., Jungles, S., Carter, R., Krieger, J. E., Manseau, E. J., Harvey, V. S., Eckelhoefer, I. A., Feng, D., Dvorak, A. M., Mulligan, R. C., and Dvorak, H. F. (2000) Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 80, 99-115 (Pubitemid 30067385)